Pfizer To Pay $2.3 Billion In Biggest Fine Ever For Deceitful Drug Marketing
The problem of course is that this is classified as a business expense and thus reduces the amount of taxes that Pfizer has to pay. If they time the payment cleverly it can be quite beneficial.
n the largest settlement ever for wrongful drug marketing, Pfizer agreed to pay a total of $2.3 billion in fines for promoting medicines for unapproved uses and will plead guilty to illegally marketing the painkiller Bextra, The Wall Street Journal reported. The settlement resolves charges raised by the Justice and Health and Human Services departments. (Bextra was pulled from the market in 2005.)
The problem of course is that this is classified as a business expense and thus reduces the amount of taxes that Pfizer has to pay. If they time the payment cleverly it can be quite beneficial.
